Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kriegsmann

Showing results (271-280 of 366) with videos related to

Pageof 37
Sort By:
Pathology International|October 20, 2017
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancerSebastian Thiem, Thomas Herold, Ulrich Krafft, et al.
Experimental and Molecular Pathology|June 27, 2015
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancerMelanie Maierthaler, Mark Kriegsmann, Cike Peng, et al.
Rheumatology International|March 14, 2003
Expression of the apoptosis accelerator Bax in rheumatoid arthritis synoviumInsa Hilbers, Torsten Hansen, Peter K Petrow, et al.
Journal of Cancer Research and Clinical Oncology|March 22, 2019
DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcomaChristian Koelsche, Mark Kriegsmann, Felix K F Kommoss, et al.
Respiration; International Review of Thoracic Diseases|August 12, 2021
Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center ExperienceLaura V Klotz, Christiane Gruenewald, Elena L Bulut, et al.
Transfusion|June 28, 2017
Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myelomaKatharina Lisenko, Marc-Andrea Baertsch, Renate Meiser, et al.
Proteomics. Clinical Applications|August 11, 2018
Microproteomic Profiling of High-Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic MarkersCharles Pottier, Mark Kriegsmann, Deborah Alberts, et al.
Clinical Lung Cancer|July 17, 2023
Prognostic Impact of the Immune-Cell Infiltrate in N1-Positive Non-Small-Cell Lung CancerFlorian Eichhorn, Andreas Weigert, Rajender Nandigama, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2023
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scanThomas Muley, Mark A Schneider, Michael Meister, et al.
Cancers|December 1, 2020
Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired PrognosisMiriam M Küster, Marc A Schneider, Antje M Richter, et al.
Pageof 37

Showing results (271-280 of 366) with videos related to

Sort By:
Pageof 37
Pathology International|October 20, 2017
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancerSebastian Thiem, Thomas Herold, Ulrich Krafft, et al.
Experimental and Molecular Pathology|June 27, 2015
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancerMelanie Maierthaler, Mark Kriegsmann, Cike Peng, et al.
Rheumatology International|March 14, 2003
Expression of the apoptosis accelerator Bax in rheumatoid arthritis synoviumInsa Hilbers, Torsten Hansen, Peter K Petrow, et al.
Journal of Cancer Research and Clinical Oncology|March 22, 2019
DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcomaChristian Koelsche, Mark Kriegsmann, Felix K F Kommoss, et al.
Respiration; International Review of Thoracic Diseases|August 12, 2021
Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center ExperienceLaura V Klotz, Christiane Gruenewald, Elena L Bulut, et al.
Transfusion|June 28, 2017
Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myelomaKatharina Lisenko, Marc-Andrea Baertsch, Renate Meiser, et al.
Proteomics. Clinical Applications|August 11, 2018
Microproteomic Profiling of High-Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic MarkersCharles Pottier, Mark Kriegsmann, Deborah Alberts, et al.
Clinical Lung Cancer|July 17, 2023
Prognostic Impact of the Immune-Cell Infiltrate in N1-Positive Non-Small-Cell Lung CancerFlorian Eichhorn, Andreas Weigert, Rajender Nandigama, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2023
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scanThomas Muley, Mark A Schneider, Michael Meister, et al.
Cancers|December 1, 2020
Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired PrognosisMiriam M Küster, Marc A Schneider, Antje M Richter, et al.
Pageof 37